Psoriasis Risk Is Lower in Type 2 Diabetes Patients Using Dipeptidyl Peptidase-4 Inhibitors or Thiazolidinediones Compared to Sulfonylureas
- Wei Sheng Chen
- , Tzu Min Lin
- , Yu Sheng Chang
- , Yu Chuan Shen
- , Hui Ching Hsu
- , Tzu Tung Kuo
- , Shu Chuan Chen
- , Jin Hua Chen
- , Chi Ching Chang
- Taipei Medical University Hospital
- Division of Allergy, Immunology and Rheumatology
- Taipei Medical University Shuang Ho Hospital
- Taipei Municipal Wanfang Hospital
- TMU Research Center of Thoracic Medicine
- Graduate Institute of Data Science
- International Ph.D. Program in Biotech and Healthcare Management
- Master Program in Applied Epidemiology
Research output: Contribution to journal › Article › peer-review